HMGB1 and Nephropathy: The present experiment corroborates these claims, and it also implies that QB may be able to inhibit the HMGB1/TLR4/MyD88 pathway, thereby reduce autoantibody production, inhibit the release of inflammatory factors, and improve kidney damage.